Validity of procalcitonin as diagnostic biomarker for infective endocarditis
Last updated: 04 Jan 2025
10.21608/svuijm.2023.212553.1589
Procalcitonin, Infective endocarditis, Duke criteria
Momen M.
Thabet
Department of Microbiology and Immunology, Faculty of Pharmacy, South Valley University, Qena, Egypt.
pharmacistmomen@gmail.com
0000-0002-0523-8443
Marwan S.
Mahmoud
Department of Cardiology, Assiut University Heart Hospital, Assiut University, Assiut, Egypt.
marwancordio@aun.edu.eg
Ayman Khairy Mohamed
Hassan
Department of Cardiology, Assiut University Heart Hospital, Assiut University, Assiut, Egypt.
ayman.hassan@aun.edu.eg
Ehsan A.
Hassan
Department of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt.
dr_ehsan66@aun.edu.eg
Khaled
Hassanein
Mohamed
Department of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt.
khaledhassanein70@aun.edu.eg
Mona Hussein
Abdel-Rahim
Department of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt.
mona.hussein@aun.edu.eg
6
2
40200
2023-07-01
2023-04-22
2023-07-01
347
352
2735-427X
2636-3402
https://svuijm.journals.ekb.eg/article_302092.html
https://svuijm.journals.ekb.eg/service?article_code=302092
32
Original research articles
1,520
Journal
SVU-International Journal of Medical Sciences
https://svuijm.journals.ekb.eg/
Validity of procalcitonin as diagnostic biomarker for infective endocarditis
Details
Type
Article
Created At
27 Dec 2024